Infanrix IPV inj. susp. i.m. pre-filled syr.

Country: Belgium

Bahasa: Inggeris

Sumber: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Beli sekarang

Bahan aktif:

Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/0,5 ml; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/0,5 ml; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Bordetella Pertussis Pertactin 8 µg/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/0,5 ml

Boleh didapati daripada:

GlaxoSmithKline Biologicals SA-NV

Kod ATC:

J07CA02

INN (Nama Antarabangsa):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Borang farmaseutikal:

Suspension for injection

Komposisi:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Laluan pentadbiran:

Intramuscular use

Kawasan terapeutik:

Diphtheria-Pertussis-Poliomyelitis-Tetanus

Ringkasan produk:

CTI code: 212152-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 212152-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - FMD code: 05400571000808 - CNK code: 1552215 - Delivery mode: Medical prescription

Status kebenaran:

Commercialised: Yes

Tarikh kebenaran:

2000-03-13

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Jerman 11-07-2023
Risalah maklumat Risalah maklumat Perancis 11-07-2023
Ciri produk Ciri produk Perancis 11-07-2023
Risalah maklumat Risalah maklumat Belanda 11-07-2023
Ciri produk Ciri produk Belanda 11-07-2023